Literature DB >> 6296685

A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions.

S I Walaas, D W Aswad, P Greengard.   

Abstract

Several mammalian neurotransmitter candidates, for example, serotonin, dopamine and noradrenaline, may exert some of their synaptic effects by regulating protein phosphorylation systems. Comparison of the regional distribution of brain phosphoproteins with neurotransmitter systems may help to identify the specific phosphoproteins involved in the functions of particular neurotransmitters. Here we report the association of one such phosphoprotein with the dopamine pathways in brain. This protein, of apparent molecular weight (MW) 32,000 (32K), seems to be present only in nervous tissue. Its regional distribution within the brain is very similar to the pattern of dopamine-containing nerve terminals; more specifically, the protein appears to be enriched in those dopaminoceptive neurones which possess D-1 receptors (dopamine receptors coupled to adenylate cyclase). The state of phosphorylation of the protein in these dopaminoceptive neurones can be regulated by both dopamine and cyclic AMP. These results suggest that the phosphoprotein may mediate certain of the trans-synaptic effects of dopamine acting on dopaminoceptive neurones.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296685     DOI: 10.1038/301069a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  88 in total

1.  Detection and quantification of protein phosphatase inhibitor-1 gene expression in total rat liver and isolated hepatocytes.

Authors:  E A Aleem; T Flohr; A Hunziker; D Mayer; P Bannasch; H W Thielmann
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

2.  Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.

Authors:  G L Snyder; P B Allen; A A Fienberg; C G Valle; R L Huganir; A C Nairn; P Greengard
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

3.  Stimulation of protein-tyrosine phosphorylation in rat striatum after lesion of dopamine neurons or chronic neuroleptic treatment.

Authors:  J A Girault; J C Siciliano; L Robel; D Hervé
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain.

Authors:  Padmesh S Rajput; Geetanjali Kharmate; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2011-11-25       Impact factor: 3.444

5.  Acute Ca(2+)-dependent desensitization of 5-HT(1A) receptors is mediated by activation of protein kinase A (PKA) in rat serotonergic neurons.

Authors:  Y Yao; P J Bergold; N J Penington
Journal:  Neuroscience       Date:  2010-04-25       Impact factor: 3.590

Review 6.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

Review 7.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

8.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission.

Authors:  R T Fremeau; G E Duncan; M G Fornaretto; A Dearry; J A Gingrich; G R Breese; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 9.  Neurocomputational models of basal ganglia function in learning, memory and choice.

Authors:  Michael X Cohen; Michael J Frank
Journal:  Behav Brain Res       Date:  2008-10-04       Impact factor: 3.332

10.  Neural connectivity as an intermediate phenotype: brain networks under genetic control.

Authors:  Andreas Meyer-Lindenberg
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.